DAAG CONFERENCE 2010
_ Florida
Session 1 — Government Methods
Session 2 — Benefit Risk
Session 3 — Org Adoption of DA
Session 4 — Case Studies
Session 5 — Analytic Comm
Session 6 — Organizational Dec Competency
Session 7 — Proj Enter Risk Mgmt
Session 8 — Black Swan
Session 1 — Government Methods
- Marvin - Making Trade Space.pdf
- Wilson - DoD Portfolio Analysis.pdf
Session 2 — Benefit Risk
- Felli - Benefit Risk A Story in Pictures.pdf
- Phillips - EMA to improve the process of balancing benefits and risks in approving drugs.pdf
- Ryan- Quantitative benefit-risk assessment.pdf
Session 3 — Org Adoption of DA
- Spetzler - ODQ Presentation DAAG.combined.pdf
Session 4 — Case Studies
- DAAG 2010_A Pilot Risk Analysis Study for an IBM Services Delivery Location.pdf
- Ruhland - Impact of Manufacturing Optimization on Portfolio Prioritization.pdf
- Swank - Assessing Consistent Probabilities of Success for Different Drug Development Plans.pdf
Session 5 — Analytic Comm
Session 6 — Organizational Dec Competency
- Andharia - Engaging and Retaining DA Practitioners.pdf
- Beccue - Transforming Culture of Startegic DM for Biotech Organization.pdf
Session 7 — Proj Enter Risk Mgmt
- Johnson - Project Derailed Finding Timeline Drivers to Get Back on Track.pdf
- McNutt - ConocoPhillips' Journey to Full Quantitative Risk Assessment for Project Cost and Schedule.pdf
- Strategy, Portfolio & Risk Mgmt.pdf
Session 8 — Black Swan